0001140361-22-045687.txt : 20221215 0001140361-22-045687.hdr.sgml : 20221215 20221215162256 ACCESSION NUMBER: 0001140361-22-045687 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20221215 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221215 DATE AS OF CHANGE: 20221215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Healthcare Services Acquisition Corp CENTRAL INDEX KEY: 0001824846 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 852754095 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39823 FILM NUMBER: 221465103 BUSINESS ADDRESS: STREET 1: 7809 WOODMONT AVENUE, SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 301-605-1309 MAIL ADDRESS: STREET 1: 7809 WOODMONT AVENUE, SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 8-K 1 brhc10045378_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 8-K


CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 15, 2022


Healthcare Services Acquisition Corporation
(Exact Name of Registrant as Specified in Charter)


Delaware
 001-39823
85-2754095
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)

7809 Woodmont Avenue, Suite 200
    
Bethesda, MD
  
20814
(Address of Principal Executive Offices)
  
(Zip Code)

Registrant’s telephone number, including area code: (301) 605-1309

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
  
Trading
Symbol(s)
 
Name of each exchange
on which registered
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant   HCARU   The Nasdaq Stock Market LLC
Class A Common Stock, par value $0.0001 per share
   HCAR
  
The Nasdaq Stock Market LLC
Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
   HCARW
  
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 8.01.
Other Events.

Due to the Company’s anticipated inability to consummate an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation, the Company intends to dissolve and liquidate in accordance with the provisions of its Amended and Restated Certificate of Incorporation and will redeem all of the shares of outstanding Class A common stock that were included in the units issued in its initial public offering (the “Public Shares”), at a per-share redemption price of approximately $10.11.

As of the close of business on December 22, 2022, the Public Shares will be deemed cancelled and will represent only the right to receive the redemption amount.

In order to provide for the disbursement of funds from the trust account, the Company has instructed the trustee of the trust account to take all necessary actions to liquidate the trust account. The proceeds of the trust account will be held in a non-interest bearing account while awaiting disbursement to the holders of the Public Shares. Record holders may redeem their shares for their pro rata portion of the proceeds of the trust account upon presentation of their respective shares or unit certificates or other delivery of their shares or units to Continental Stock Transfer & Trust Company, the Company’s transfer agent. Beneficial owners of Public Shares held in “street name,” however, will not need to take any action to receive the redemption amount. The redemption of the Public Shares is expected to be completed within ten business days after December 22, 2022.

The Company’s initial stockholders have waived their redemption rights with respect to its outstanding common stock issued prior to the Company’s initial public offering.

There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless.

The Company expects that Nasdaq will file a Form 25 with the United States Securities and Exchange Commission (the “SEC”) to delist the Company’s securities. The Company thereafter expects to file a Form 15 with the SEC to terminate the registration of its securities under the Securities Exchange Act of 1934, as amended.

On December 15, 2022, the Company issued a press release announcing that the Company intends to dissolve and liquidate in accordance with the provisions of its Amended and Restated Certificate of Incorporation and will redeem all of its Public Shares. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01.
Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are filed with this Form 8-K:

Exhibit No.
Description
Press Release, dated December 15, 2022
104
Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: December 15, 2022
  
Healthcare Services Acquisition Corporation
   
 
By:
  
/s/ Joshua B. Lynn
Name:
  
Joshua B. Lynn
Title:
  
Chief Executive Officer


EX-99.1 2 brhc10045378_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1

Healthcare Services Acquisition Corporation Announces Liquidation

Bethesda, MD - Healthcare Services Acquisition Corporation (“Healthcare Services”) (Nasdaq: HCAR, HCARU and HCARW), announced today that, due to its anticipated inability to consummate an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation, Healthcare Services intends to dissolve and liquidate in accordance with the provisions of its Amended and Restated Certificate of Incorporation and will redeem all of the outstanding shares of Class A common stock that were included in the units issued in its initial public offering (the “Public Shares”), at a per-share redemption price of approximately $10.11.

As of the close of business on December 22, 2022, the Public Shares will be deemed cancelled and will represent only the right to receive the redemption amount.

In order to provide for the disbursement of funds from the trust account, the Company has instructed the trustee of the trust account to take all necessary actions to liquidate the trust account. The proceeds of the trust account will be held in a non-interest bearing account while awaiting disbursement to the holders of the Public Shares. Record holders may redeem their shares for their pro rata portion of the proceeds of the trust account upon presentation of their respective shares or unit certificates or other delivery of their shares or units to Continental Stock Transfer & Trust Company, the Company’s transfer agent. Beneficial owners of Public Shares held in “street name,” however, will not need to take any action in order to receive the redemption amount. The redemption of the Public Shares is expected to be completed within ten business days after December 22, 2022.

The Company’s initial stockholders have waived their redemption rights with respect to its outstanding common stock issued prior to the Company’s initial public offering.

There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless.

The Company expects that Nasdaq will file a Form 25 with the United States Securities and Exchange Commission (the “SEC”) to delist its securities. The Company thereafter expects to file a Form 15 with the SEC to terminate the registration of its securities under the Securities Exchange Act of 1934, as amended.

About Healthcare Services Acquisition Corporation

Healthcare Services is a blank check company organized for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Forward-Looking Statements

This press release may include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are based on the beliefs and reasonable assumptions of management, and actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the SEC. The Company undertakes no obligation to update any forward-looking statements after the date of this release, except as required by law.

Contact
media@healthcarespac.com


 EX-101.SCH 3 hcar-20221215.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 hcar-20221215_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 hcar-20221215_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Domain] Common Class A [Member] Class of Stock [Axis] Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Ex Transition Period Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Listings [Table] Entity Listings [Line Items] Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share [Member] Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant [Member] EX-101.PRE 6 hcar-20221215_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document and Entity Information
Dec. 15, 2022
Entity Listings [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 15, 2022
Entity File Number 001-39823
Entity Registrant Name Healthcare Services Acquisition Corporation
Entity Central Index Key 0001824846
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 85-2754095
Entity Address, Address Line One 7809 Woodmont Avenue, Suite 200
Entity Address, City or Town Bethesda
Entity Address, State or Province MD
Entity Address, Postal Zip Code 20814
City Area Code 301
Local Phone Number 605-1309
Entity Emerging Growth Company true
Entity Ex Transition Period false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant
Trading Symbol HCARU
Security Exchange Name NASDAQ
Common Class A [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share
Trading Symbol HCAR
Security Exchange Name NASDAQ
Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
Trading Symbol HCARW
Security Exchange Name NASDAQ
XML 8 brhc10045378_8k_htm.xml IDEA: XBRL DOCUMENT 0001824846 2022-12-15 2022-12-15 0001824846 hcar:UnitsEachConsistingOfOneShareOfClassACommonStock00001ParValueAndOneHalfOfOneRedeemableWarrantMember 2022-12-15 2022-12-15 0001824846 us-gaap:CommonClassAMember 2022-12-15 2022-12-15 0001824846 hcar:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockEachAtAnExercisePriceOf1150PerShareMember 2022-12-15 2022-12-15 false 0001824846 MD 8-K 2022-12-15 Healthcare Services Acquisition Corporation DE 001-39823 85-2754095 7809 Woodmont Avenue, Suite 200 Bethesda 20814 301 605-1309 false false false false Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant HCARU NASDAQ Class A Common Stock, par value $0.0001 per share HCAR NASDAQ Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share HCARW NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 4 23 1 false 3 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://healthcarespac.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressStateOrProvince - brhc10045378_8k.htm 11 brhc10045378_8k.htm brhc10045378_ex99-1.htm hcar-20221215.xsd hcar-20221215_def.xml hcar-20221215_lab.xml hcar-20221215_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc10045378_8k.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 4, "dts": { "definitionLink": { "local": [ "hcar-20221215_def.xml" ] }, "inline": { "local": [ "brhc10045378_8k.htm" ] }, "labelLink": { "local": [ "hcar-20221215_lab.xml" ] }, "presentationLink": { "local": [ "hcar-20221215_pre.xml" ] }, "schema": { "local": [ "hcar-20221215.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 37, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 2, "memberStandard": 1, "nsprefix": "hcar", "nsuri": "http://healthcarespac.com/20221215", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "brhc10045378_8k.htm", "contextRef": "c20221215to20221215", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://healthcarespac.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "brhc10045378_8k.htm", "contextRef": "c20221215to20221215", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 3, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityListingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Listings [Line Items]" } } }, "localname": "EntityListingsLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityListingsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container for exchange listing information for an entity", "label": "Entity Listings [Table]" } } }, "localname": "EntityListingsTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "trueItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "hcar_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockEachAtAnExercisePriceOf1150PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share [Member]" } } }, "localname": "RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockEachAtAnExercisePriceOf1150PerShareMember", "nsuri": "http://healthcarespac.com/20221215", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "hcar_UnitsEachConsistingOfOneShareOfClassACommonStock00001ParValueAndOneHalfOfOneRedeemableWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant [Member]" } } }, "localname": "UnitsEachConsistingOfOneShareOfClassACommonStock00001ParValueAndOneHalfOfOneRedeemableWarrantMember", "nsuri": "http://healthcarespac.com/20221215", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://healthcarespac.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 16 0001140361-22-045687-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-22-045687-xbrl.zip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end